The Norman Transcript

Archive

December 22, 2012

education news roundup

(Continued)

NORMAN —

· The HIRE Internship Site of the Year went to Habitat for Humanity. 

Other awards presented at the event were: 

· Ambassador Award – awarded to the student who has been an outstanding reflection of the program on and off campus: Sakedra Kelley

· Outstanding Attendance – awarded to the student with the highest overall attendance for the last year: Joseph Walsh

· The Diamond Award – awarded to the student who has displayed commitment to the development of character in his or her personal life: Fatamia Rucker

· The Bulldog Award – awarded to the student who has shown the most tenacity in the pursuit of his or her goals: Brianna Robbins

MNTC’s HIRE program is a leader in providing education and employment services to Oklahomans receiving TANF (Temporary Assistance for Needy families). Since 1993, MNTC’s HIRE program has provided hundreds of individuals with the technical and personal skills and support necessary to become successful in today’s workplace.

To learn about MNTC’s full-time class options visit www.mntechnology.com or call 405-364-5763.

University of Oklahoma / Integris team up for grant:Oklahoma’s largest not-for-profit healthcare system and one fo the state’s public universities have combined efforts and were recently awarded for their collaboration.

INTEGRIS Baptist Medical Center Research scientist Trevor Snyder, Ph.D. and University of Oklahoma Associate Professor and Bioengineering Director David Schmidtke, Ph.D., recently received a two year, $488,883 grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to investigate changes in the function of platelets caused by implantable blood pumps for severe heart failure.

Based on apparent damage to proteins involved in blood clotting caused by ventricular assist devices, or VADs, Snyder and Schmidtke will use the grant to investigate why some patients who receive VADs have episodes of bleeding. They hope to improve the design of the VAD and perfect pharmaceutical development for patients suffering from heart failure or blood issues.

Text Only | Photo Reprints